| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.06 |